Skip to content
healthcare.dev

Cystadane

NDC 52276-400, betaine, powder, for solution, from Recordati Rare Diseases.

Product NDC
52276-400
Status
Listed
Labeler
Recordati Rare Diseases
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020576
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52276-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BETAINE1 g/g

Pharmacologic classes

Methylating Activity [MoA]; Methylating Agent [EPC]

Package NDCNDC-11Package
52276-400-0152276040001180 g in 1 BOTTLE (52276-400-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/31a684d0-cd98-4e46-b43a-ccbd17c41559

Use it

Look up 52276-400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52276-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52276-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.